PSEN2 and Alzheimer disease: Thus, our current study suggests that the use of the acute 6-Hz limbic seizure model evoked in PSEN2-KO mice may beneficially identify both effective and well-tolerated agents for future clinical investigation to better therapeutically manage seizures in people with AD.